Risk of Leaking heart valves with Fluoroquinolone class of antibiotics: Drug Safety Alert Health Canada

Drug Safety Alert, Global Safety Alerts, Health Canada, Medicinal Product Updates, Safety Communications, ,

Safety update: Potential Risk of leaking heart valves (heart valve regurgitation) associated with the use of antibiotics belonging to the Fluoroquinolone class which included ciprofloxacin-, levofloxacin-, moxifloxacin- and norfloxacin-containing medicinal products which are administered by injection or by mouth (systemic) and by breathing in (inhaled). Fluoroquinolones broader spectrum antibiotics which are used in the treatment…

Read More

Drug Safety Updates from Health Canada-June 2020

Drug Safety Alert from Health Canada

Drug Safety Alert, Drug Safety Updates, Pharmacovigilance, ,

Health Canada has released a new drug safety information/alert to raise awareness to health care professionals and public about the below safety concern which recently made safety labelling changes for the product monograph. –Health Product Info Watch – May 2020. The safety concern discussed below in brief. Hypofibrinogenaemia associated with Tigecycline use: Tigecycline is a…

Read More

Drug Safety Updates from Health Canada-June 2020

Drug Safety Alerts from Health Canada

Drug Safety Signal, Drug Safety Updates, Pharmacovigilance, , , , ,

Health Canada has released two new drug safety alerts to raise awareness to health care professionals and public about the two safety concerns which recently made safety labelling changes for the respective product monographs. –Health Product Info Watch – April 2020. Below are the two safety concerns discussed in brief. Interstitial lung disease risk associated…

Read More

error: Content is protected !!